<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03915717</url>
  </required_header>
  <id_info>
    <org_study_id>2019-01</org_study_id>
    <nct_id>NCT03915717</nct_id>
  </id_info>
  <brief_title>Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring</brief_title>
  <official_title>Observational Study of Outcomes After EchoMark and EchoSure-based Free Flap Monitoring</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sonavex, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sonavex, Inc.</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the performance of the EchoMark and EchoSure as an
      ultrasound-based method of monitoring the viability of free flaps and patency of at-risk
      vessels.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 19, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Surgeon evaluation of improved monitoring ability via questionnaire with likert scale</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Surgeon evaluation of satisfaction via questionnaire with likert scale</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Flap failure rate</measure>
    <time_frame>Through patient stay, up to 5 days post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flap takeback rate</measure>
    <time_frame>Through patient stay, up to 5 days post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Flap salvage rate</measure>
    <time_frame>Through patient stay, up to 5 days post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total cost of hospitalization</measure>
    <time_frame>Through patient stay, up to 5 days post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time from OR departure to return to OR</measure>
    <time_frame>Through patient stay, up to 5 days post-op</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nurse evaluation of improved monitoring via questionnaire with likert scale</measure>
    <time_frame>Through study completion, an average of 1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Free Flap Transfer</condition>
  <condition>Malignant Neoplasm</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EchoMark</intervention_name>
    <description>EchoMark is implanted during surgery to mark the at-risk blood vessels to enable EchoSure ultrasound-based monitoring</description>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EchoSure</intervention_name>
    <description>EchoSure ultrasound scans are performed to monitor the free flap</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients undergoing free flap surgery
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age &gt; 18 years

          -  Patients presenting for microvascular tissue transfer procedures where the surgeon has
             selected EchoMark and EchoSure as the optimal method of vascular monitoring based on
             clinical assessment and plan

          -  Patient is able to sign informed consent and able to participate in all testing
             associated with this clinical investigation

          -  Women of childbearing potential have a negative pregnancy test

        Exclusion Criteria:

          -  Age &lt;18 years old

          -  Patient unable to sign informed consent

          -  Patient participating in another investigational device or pharmacological study

          -  Prisoner or patient from vulnerable populations as defined in 45 CFR 46.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <location>
    <facility>
      <name>University of Pennsylvania</name>
      <address>
        <city>Philadelphia</city>
        <state>Pennsylvania</state>
        <zip>19104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elizabeth Beothy</last_name>
      <phone>215-614-0036</phone>
      <email>beothye@uphs.upenn.edu</email>
    </contact>
    <investigator>
      <last_name>Steven Cannady, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>April 10, 2019</study_first_submitted>
  <study_first_submitted_qc>April 13, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 16, 2019</study_first_posted>
  <last_update_submitted>March 19, 2020</last_update_submitted>
  <last_update_submitted_qc>March 19, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

